XENON PHARMACEUTICALS INC's ticker is XENE and the CUSIP is 98420N105. A total of 35 filers reported holding XENON PHARMACEUTICALS INC in Q1 2018. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $14,593,012 | +44.6% | 427,125 | +63.0% | 0.01% | +66.7% |
Q2 2023 | $10,090,975 | +332.0% | 262,107 | +301.6% | 0.00% | +200.0% |
Q1 2023 | $2,335,870 | +18725.5% | 65,266 | -79.3% | 0.00% | -75.0% |
Q4 2022 | $12,408 | -99.9% | 314,673 | -8.0% | 0.00% | -20.0% |
Q3 2022 | $12,348,000 | +132.0% | 342,031 | +95.5% | 0.01% | +150.0% |
Q2 2022 | $5,322,000 | -40.7% | 174,962 | -40.4% | 0.00% | -33.3% |
Q1 2022 | $8,979,000 | -1.5% | 293,729 | +0.6% | 0.00% | 0.0% |
Q4 2021 | $9,120,000 | +294.8% | 291,946 | +93.1% | 0.00% | +200.0% |
Q3 2021 | $2,310,000 | +728.0% | 151,197 | +907.3% | 0.00% | – |
Q2 2021 | $279,000 | +153.6% | 15,010 | +35.0% | 0.00% | – |
Q2 2019 | $110,000 | -2.7% | 11,120 | 0.0% | 0.00% | – |
Q1 2019 | $113,000 | +61.4% | 11,120 | 0.0% | 0.00% | – |
Q4 2018 | $70,000 | -52.4% | 11,120 | 0.0% | 0.00% | – |
Q3 2018 | $147,000 | +44.1% | 11,120 | 0.0% | 0.00% | – |
Q2 2018 | $102,000 | +88.9% | 11,120 | 0.0% | 0.00% | – |
Q1 2018 | $54,000 | +74.2% | 11,120 | 0.0% | 0.00% | – |
Q4 2017 | $31,000 | – | 11,120 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Ghost Tree Capital, LLC | 790,000 | $12,071,000 | 3.53% |
GREAT POINT PARTNERS LLC | 700,000 | $10,696,000 | 2.49% |
COMMODORE CAPITAL LP | 579,432 | $8,854,000 | 2.33% |
ACUTA CAPITAL PARTNERS, LLC | 417,409 | $6,378,000 | 2.25% |
DAFNA Capital Management LLC | 406,535 | $6,212,000 | 1.65% |
Tri Locum Partners LP | 264,134 | $4,036,000 | 1.60% |
Parkman Healthcare Partners LLC | 311,207 | $4,755,000 | 1.20% |
Ghost Tree Capital, LLC | 250,000 | $3,820,000 | 1.12% |
Nan Fung Group Holdings Ltd | 197,880 | $3,024,000 | 0.97% |
BVF INC/IL | 1,571,778 | $24,017,000 | 0.94% |